Jong Hoon Kim
0000-0002-3385-8180
Yonsei University College of Medicine
2 papers found
Refreshing results…
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers
Missing publications? Search for publications with a matching author name.